Cindy Motz
Stock Analyst at Goldman Sachs
(n/a)
# 4,642
Out of 5,057 analysts
14
Total ratings
8.33%
Success rate
-30%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cindy Motz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Upgrades: Neutral | $64 → $77 | $99.50 | -22.61% | 3 | Oct 21, 2022 | |
| HCAT Health Catalyst | Maintains: Buy | $29 → $18 | $2.35 | +665.96% | 5 | Aug 10, 2022 | |
| DOCS Doximity | Maintains: Buy | $53 → $46 | $49.72 | -7.48% | 3 | Aug 8, 2022 | |
| TDOC Teladoc Health | Downgrades: Neutral | $55 → $36 | $7.07 | +409.19% | 3 | Jul 28, 2022 |
HealthEquity
Oct 21, 2022
Upgrades: Neutral
Price Target: $64 → $77
Current: $99.50
Upside: -22.61%
Health Catalyst
Aug 10, 2022
Maintains: Buy
Price Target: $29 → $18
Current: $2.35
Upside: +665.96%
Doximity
Aug 8, 2022
Maintains: Buy
Price Target: $53 → $46
Current: $49.72
Upside: -7.48%
Teladoc Health
Jul 28, 2022
Downgrades: Neutral
Price Target: $55 → $36
Current: $7.07
Upside: +409.19%